NCT05154136View on ClinicalTrials.gov

A Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetic Profile of Etrumadenant in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

December 10, 2021

Study Completion Date

December 10, 2021

Conditions
Healthy Participants
Interventions
DRUG

Etrumadenant

Capsule

DRUG

Itraconazole

Capsule

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors
All Listed Sponsors
lead

Arcus Biosciences, Inc.

INDUSTRY

NCT05154136 - A Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetic Profile of Etrumadenant in Healthy Adult Participants | Biotech Hunter | Biotech Hunter